Why CRH Medical Corporation (TSE:CRH) Could Be Worth WatchingHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Why CRH Medical Corporation (TSE:CRH) Could Be Worth WatchingSimply Wall StSimply Wall St.January 8, 2020ReblogShareTweetShareView photosCRH Medical Corporation (TSE:CRH), which is in the healthcare business, and is based in Canada, saw a significant share price rise of over 20% in the past couple of months on the TSX. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, could the stock still be trading at a relatively cheap price? Let’s take a look at CRH Medical’s outlook and value based on the most recent financial data to see if the opportunity still exists. Check out our latest analysis for CRH Medical Is CRH Medical still cheap?According to my relative valuation model, the stock is currently overvalued. I’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 65.43x is currently well-above the industry average of 40.9x, meaning that it is trading at a more expensive price relative to its peers. If you like the stock, you may want to keep an eye out for a potential price decline in the future. Given that CRH Medical’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.Can we expect growth from CRH Medical?TSX:CRH Past and Future Earnings, January 8th 2020MoreFuture outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. CRH Medical’s earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.What this means for you:Are you a shareholder? CRH’s optimistic future growth appears to have been factored into the current share price, with shares trading above its fair value. However, this brings up another question – is now the right time to sell? If you believe CRH should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.Are you a potential investor? If you’ve been keeping an eye on CRH for a while, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for CRH, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on CRH Medical. You can find everything you need to know about CRH Medical in the latest infographic research report. If you are no longer interested in CRH Medical, you can use our free platform to see my list of over 50 other stocks with a high growth potential.If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextHere's What Absolent Group AB (publ)'s (STO:ABSO) P/E Is Telling UsSimply Wall St.Timeless Software (HKG:8028) Shareholders Have Enjoyed A 51% Share Price GainSimply Wall St.Is There Now An Opportunity In NetDragon Websoft Holdings Limited (HKG:777)?Simply Wall St.Imagine Owning CommsChoice Group (ASX:CCG) And Wondering If The 36% Share Price Slide Is JustifiedSimply Wall St.If You Had Bought Automated Systems Holdings (HKG:771) Stock A Year Ago, You'd Be Sitting On A 14% Loss, TodaySimply Wall St.Biocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoIndia Stocks Extend Slide, Heading for Worst Week in Four YearsBloombergMost face masks won’t protect you from the coronavirusYahoo Finance'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video